Nutex Health Inc. (NASDAQ:NUTX – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Thursday . The company traded as high as $201.49 and last traded at $193.9440, with a volume of 31238 shares trading hands. The stock had previously closed at $190.71.
Analyst Ratings Changes
NUTX has been the subject of a number of research reports. Zacks Research raised shares of Nutex Health to a “hold” rating in a report on Monday, June 29th. B. Riley Financial assumed coverage on shares of Nutex Health in a report on Friday, June 26th. They set a “buy” rating and a $290.00 price target on the stock. Wall Street Zen upgraded shares of Nutex Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. Lake Street Capital began coverage on shares of Nutex Health in a research note on Tuesday, June 2nd. They issued a “buy” rating and a $235.00 price objective for the company. Finally, Weiss Ratings upgraded shares of Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research report on Monday, May 4th. Three research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, Nutex Health has a consensus rating of “Moderate Buy” and a consensus price target of $243.33.
Check Out Our Latest Analysis on Nutex Health
Nutex Health Price Performance
Nutex Health (NASDAQ:NUTX – Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The company reported $6.52 EPS for the quarter, beating analysts’ consensus estimates of $3.99 by $2.53. The firm had revenue of $216.49 million for the quarter, compared to analyst estimates of $227.80 million. Nutex Health had a return on equity of 23.50% and a net margin of 10.95%. On average, equities research analysts forecast that Nutex Health Inc. will post 22.72 EPS for the current year.
Institutional Investors Weigh In On Nutex Health
Several hedge funds have recently added to or reduced their stakes in the business. Deutsche Bank AG raised its stake in shares of Nutex Health by 3.9% during the fourth quarter. Deutsche Bank AG now owns 2,633 shares of the company’s stock valued at $433,000 after acquiring an additional 98 shares during the last quarter. Russell Investments Group Ltd. increased its holdings in Nutex Health by 1.4% in the fourth quarter. Russell Investments Group Ltd. now owns 8,706 shares of the company’s stock valued at $1,433,000 after purchasing an additional 116 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al increased its holdings in Nutex Health by 3.7% in the fourth quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 5,600 shares of the company’s stock valued at $922,000 after purchasing an additional 200 shares during the period. Islay Capital Management LLC bought a new position in Nutex Health during the 4th quarter worth $34,000. Finally, First Trust Advisors LP raised its position in Nutex Health by 2.4% during the 4th quarter. First Trust Advisors LP now owns 11,461 shares of the company’s stock worth $1,887,000 after purchasing an additional 272 shares during the last quarter. 5.32% of the stock is currently owned by institutional investors and hedge funds.
Nutex Health Company Profile
Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.
The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.
Read More
- Five stocks we like better than Nutex Health
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.
